Author:
Koga Mitsuhisa,Kanaoka Yuki,Ohkido Yuma,Kubo Naoka,Ohishi Kaoru,Sugiyama Keita,Yamauchi Atsushi,Kataoka Yasufumi
Funder
Grants-in Aid for Scientific Research
Central Research Institute of Fukuoka University
Subject
Cell Biology,Molecular Biology,Biochemistry,Biophysics
Reference24 articles.
1. G. Office of the Surgeon, S. Office on, Health, Reports of the Surgeon General, The Health Consequences of Smoking: A Report of the Surgeon General, Centers for Disease Control and Prevention (US), Atlanta (GA), 2004.
2. Cancer, cigarette smoking and premature death in Europe: a review including the Recommendations of European Cancer Experts Consensus Meeting, Helsinki, October 1996;Boyle;Lung Cancer,1997
3. The effects of a smoking cessation intervention on 14.5-year mortality a randomized clinical trial;Anthonisen;Ann. Intern. Med.,2005
4. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation;Coe;J. Med. Chem.,2005
5. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors;Mihalak;Mol. Pharmacol.,2006
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献